Celltrion, Inc., a South Korean biopharmaceutical company, has developed novel human monoclonal antibodies against influenza virus infection, which neutralize a broad spectrum of influenza viruses, including pandemic H1N1 and the deadly H5N1 avian influenza virus. Preliminary tests in laboratory animals indicate that the novel human monoclonal antibodies can be used to prevent disease when given ...

My cousin told me about this - "The Regional Trial Court has ordered a 30-day status quo on the contested property occupied by the Department of Agriculture which the Cebu provincial government sought to recover."

We live in terrifying times: Pandemics ranging from bird flu to swine flu regularly threatening to kill millions. Can architecture deal with those problems?

"JAKARTA, March 10 (Reuters) - Following is a list of events in Indonesia as well as news stories and press reports which may influence financial markets."

From ES.REUTERS.COM